According to a 6 March 2026 announcement, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (short name “BAIYUNSHAN PH,” stock code 00874) provided details regarding its Board of Directors and four key committees.

The Board comprises five executive directors—led by Chairperson Li Xiaojun and Vice Chairperson Chen Jiehui—and four independent non-executive directors. Committee assignments reflect specialized oversight across audit, strategic development and investment, nomination and remuneration, and budget matters. Li Xiaojun serves as the chairperson of the Board, while certain independent non-executive directors hold committee chair roles to provide balance and supervision.

The announcement also underscores that each Board member is additionally responsible for membership in various committees, such as Audit, Strategic Development and Investment, Nomination and Remuneration, or Budget, ensuring diversified guidance and governance. The release emphasizes the importance of transparent leadership responsibilities for BAIYUNSHAN PH (00874) going forward.